BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blair AB, Yin LD, Pu N, Yu J, Groot VP, Rozich NS, Javed AA, Zheng L, Cameron JL, Burkhart RA, Weiss MJ, Wolfgang CL, He J. Recurrence in Patients Achieving Pathological Complete Response After Neoadjuvant Treatment for Advanced Pancreatic Cancer. Ann Surg 2021;274:162-9. [PMID: 32304375 DOI: 10.1097/SLA.0000000000003570] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Blair AB, Gemenetzis G, He J. The Role of Diffusion-Weighted Magnetic Resonance Imaging in Staging After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma: Reply. Ann Surg Oncol 2022. [PMID: 35437667 DOI: 10.1245/s10434-022-11737-4] [Reference Citation Analysis]
2 Luu AM, Belyaev O, Höhn P, Praktiknjo M, Janot M, Uhl W, Braumann C. Late recurrences of pancreatic cancer in patients with long-term survival after pancreaticoduodenectomy. J Gastrointest Oncol 2021;12:474-83. [PMID: 34012641 DOI: 10.21037/jgo-20-433] [Reference Citation Analysis]
3 Lu TP, Wu CH, Chang CC, Chan HC, Chattopadhyay A, Lee WC, Chiang CJ, Lee HY, Tien YW. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry. Ann Surg Oncol 2021. [PMID: 34775547 DOI: 10.1245/s10434-021-11030-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rangelova E, Bratlie SO. How to select the most appropriate adjuvant treatment after neoadjuvant treatment and resection for locally advanced pancreatic cancer? J Gastrointest Oncol 2021;12:2521-35. [PMID: 34790413 DOI: 10.21037/jgo-21-474] [Reference Citation Analysis]